News
USPSTF goes neutral on adolescent scoliosis screening
Studies since 2004 suggest that the USPSTF “no longer has moderate certainty that the harms of treatment outweigh the benefits.”
News
Idalopirdine falls short in three phase 3 Alzheimer’s trials
Simultaneously, Axovant Life Sciences pulls plug on intepirdine, another 5-HT6 receptor drug, after failures in both AD and Lewy body dementia.
News
Modeling study: Screening, treatment effects on breast cancer mortality vary by subtype
Breast cancer mortality reductions over time are associated with treatment and screening advances but vary by molecular subtype of disease.
News
VAMPIRE 3: Embolic filter for primary PCI reduces MACE
DENVER – Why experts predict the impressive results won’t change U.S. practice.
News
Team finds way to target MYB in AML
Researchers say they have found a way to target the oncogenic transcription factor MYB in acute myeloid leukemia (AML). By inducing the...
News
Update of gene therapy in hemophilia A
ATLANTA—Updated trial results have shown that gene therapy can increase factor VIII (FVIII) levels and reduce the need for FVIII infusions in...
News
Overcoming resistance to ibrutinib in CLL
New research appears to explain why ibrutinib may be less effective in certain patients with chronic lymphocytic leukemia (CLL). It seems the...
Article
Does Azithromycin Have a Role in Cesarean Sections?
Adding azithromycin to the usual antibiotic protocol in nonelective c-sections reduces infections, research shows. But not everyone can take...
News
Clinical Trial: The Checklist to Prevent MRSA Surgical Site Infections
The VA has developed a new checklist which will be tested in hopes of reducing MRSA surgical site infections.
News
Omalizumab for chronic urticaria quells suffocation fears
GENEVA – The X-ACT study spotlights profound quality-of-life impairment in patients with chronic spontaneous urticaria.